{"brief_title": "Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita", "brief_summary": "OBJECTIVES: I. Evaluate immunomodulation with extracorporeal photochemotherapy (ECP) in patients with epidermolysis bullosa acquisita. II. Investigate the effect of ECP on lymphocyte activity.", "detailed_description": "PROTOCOL OUTLINE: Oral methoxsalen (8-MOP) is administered 90 minutes prior to leukapheresis. Blood mononuclear cells are exposed to ultraviolet A light for 3 hours, then returned to the patient. The process is repeated on 2 successive days. Patients are re-treated every 3 to 4 weeks for a total of 6 treatments or until the skin has cleared.", "condition": "Epidermolysis Bullosa Acquisita", "intervention_type": "Drug", "intervention_name": "methoxsalen", "criteria": "- Active epidermolysis bullosa acquisita", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00004359.xml"}